JT Stratford LLC’s Novavax NVAX Stock Holding History

JT Stratford LLC’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,640	Closed	-$521K	–	224
2021 Q4	$521K	Sell	3,640 -405	-10%	-$69.6K	0.14%	131
2021 Q3	$839K	Buy	4,045 +254	+7%	+$56K	0.26%	87
2021 Q2	$805K	Buy	3,791 +37	+1%	+$6.78K	0.26%	99
2021 Q1	$681K	Sell	3,754 -394	-9%	-$78.5K	0.24%	97
2020 Q4	$463K	Buy	4,148 +1,764	+74%	+$187K	0.17%	112
2020 Q3	$258K	Buy	+2,384	New	+$290K	0.11%	122

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JT Stratford LLC's NVAX Position: Q1 2022 in Review

JT Stratford LLC sold out of Novavax (NVAX) in Q1 2022, closing a stake of 3,640 shares — an estimated $521K sold.

JT Stratford LLC first reported a position in NVAX in Q3 2020 and held it in 6 quarters. The position peaked at $839K in Q3 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

JT Stratford LLC reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
JT Stratford LLC sold 3,640 Novavax shares in Q1 2022, an estimated $521K.
JT Stratford LLC first reported a position in Novavax in Q3 2020 and held it in 6 quarters.
JT Stratford LLC's Novavax position peaked at $839K in Q3 2021.
381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on JT Stratford LLC's 13F filing for Q1 2022, filed 12 May 2022.